Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems
Abstract
:1. Introduction
2. Materials and Methods
2.1. PASSI and PASSI D’Argento Data Collections
2.2. Outcome Definition and Study Variables
2.3. Statistical Analysis
3. Results
3.1. Sample Characteristics
3.2. Regression Model Results
4. Discussion
Limitations and Strengths
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO—World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available online: https://covid19.who.int/ (accessed on 16 June 2023).
- Declich, S.; De Ponte, G.; Marchetti, G.; Dente, M.G.; Tosti, M.E.; Tavoschi, L.; Lopalco, P.L.; Russo, M.L.; Marceca, M. Life-course vaccinations for migrants and refugees: Drawing lessons from the COVID-19 vaccination campaigns. J. Glob. Health 2022, 12, 03064. [Google Scholar] [CrossRef]
- Davies, A.; Basten, A.; Frattini, C. Migration: A Social Determinant of the Health of Migrants. Eurohealth 2009, 16, 10–12. [Google Scholar]
- De Vito, E.; Parente, P.; de Waure, C.; Poscia, A.; Ricciardi, W. A Review of Evidence on Equitable Delivery, Access and Utilization of Immunization Services for Migrants and Refugees in the WHO European Region; Health Evidence Network Synthesis Report 53; WHO Regional Office for Europe: Geneva, Switzerland, 2017. [Google Scholar]
- Mipatrini, D.; Stefanelli, P.; Severoni, S.; Rezza, G. Vaccinations in migrants and refugees: A challenge for European health systems. A systematic review of current scientific evidence. Pathog. Glob. Health 2017, 111, 59–68. [Google Scholar] [CrossRef]
- WHO—World Health Organization. Ensuring the Integration of Refugees and Migrants in Immunization Policies, Planning and Service Delivery Globally; Global Evidence Review on Health and Migration (GEHM) Series; WHO: Geneva, Switzerland, 2022. [Google Scholar]
- WHO—World Health Organization. Promoting the Health of Refugees and Migrants: Experiences from around the World; WHO: Geneva, Switzerland, 2023. [Google Scholar]
- Greenaway, C.; Hargreaves, S.; Barkati, S.; Coyle, C.M.; Gobbi, F.; Veizis, A.; Douglas, P. COVID-19: Exposing and addressing health disparities among ethnic minorities and migrants. J. Travel. Med. 2020, 27, taaa113. [Google Scholar] [CrossRef]
- Hayward, S.E.; Deal, A.; Cheng, C.; Crawshaw, A.; Orcutt, M.; Vandrevala, T.F.; Norredam, M.; Carballo, M.; Ciftci, Y.; Requena-Méndez, A.; et al. Clinical outcomes and risk factors for COVID-19 among migrant populations in high-income countries: A systematic review. J. Migr. Health 2021, 3, 100041. [Google Scholar] [CrossRef]
- Phiri, P.; Delanerolle, G.; Al-Sudani, A.; Rathod, S. COVID-19 and Black, Asian, and Minority Ethnic Communities: A Complex Relationship Without Just Cause. JMIR Public Health Surveill. 2021, 7, e22581. [Google Scholar] [CrossRef] [PubMed]
- Sze, S.; Pan, D.; Nevill, C.R.; Gray, L.J.; Martin, C.A.; Nazareth, J.; Minhas, J.S.; Divall, P.; Khunti, K.; Abrams, K.R.; et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 2020, 29, 100630. [Google Scholar] [CrossRef]
- Jaljaa, A.; Caminada, S.; Tosti, M.E.; D’Angelo, F.; Angelozzi, A.; Isonne, C.; Marchetti, G.; Mazzalai, E.; Giannini, D.; Turatto, F.; et al. Risk of SARS-CoV-2 infection in migrants and ethnic minorities compared with the general population in the European who region during the first year of the pandemic: A systematic review. BMC Public Health 2022, 22, 143. [Google Scholar] [CrossRef] [PubMed]
- Mazzalai, E.; Giannini, D.; Tosti, M.E.; D’Angelo, F.; Declich, S.; Jaljaa, A.; Caminada, S.; Turatto, F.; De Marchi, C.; Gatta, A.; et al. Risk of COVID-19 Severe Outcomes and Mortality in Migrants and Ethnic Minorities Compared to the General Population in the European WHO Region: A Systematic Review. J. Int. Migr. Integr. 2023, 24, 1305–1335. [Google Scholar] [CrossRef] [PubMed]
- WHO. WHO COVID-19 Dashboard. Available online: https://ourworldindata.org/covid-deaths (accessed on 17 January 2024).
- Fabiani, M.; Mateo-Urdiales, A.; Andrianou, X.; Bella, A.; Del Manso, M.; Bellino, S.; Rota, M.C.; Boros, S.; Vescio, M.F.; D’Ancona, F.P.; et al. Epidemiological characteristics of COVID-19 cases in non-Italian nationals notified to the Italian surveillance system. Eur. J. Public Health 2021, 31, 37–44. [Google Scholar] [CrossRef] [PubMed]
- Fabiani, M.; Vescio, M.F.; Bressi, M.; Mateo-Urdiales, A.; Petrone, D.; Spuri, M.; Sacco, C.; Del Manso, M.; Bella, A.; D’Ancona, F.; et al. Differences in the incidence and clinical outcomes of SARS-CoV-2 infection between Italian and non-Italian nationals using routine data. Public Health 2022, 211, 136–143. [Google Scholar] [CrossRef]
- Maifredi, G.; Izzo, I.; Gasparotti, C.; Sileo, C.V.; Hiv-CoVGroup Castelli, F.; Quiros-Roldan, E. SARS-CoV-2 Infection and Vaccination Coverage among Fragile Populations in a Local Health Area of Northern Italy. Life 2022, 12, 1009. [Google Scholar] [CrossRef] [PubMed]
- Pagani, G.; Conti, F.; Giacomelli, A.; Oreni, L.; Beltrami, M.; Pezzati, L.; Casalini, G.; Rondanin, R.; Prina, A.; Zagari, A.; et al. Differences in the Prevalence of SARS-CoV-2 Infection and Access to Care between Italians and Non-Italians in a Social-Housing Neighbourhood of Milan, Italy. Int. J. Environ. Res. Public Health 2021, 18, 10621. [Google Scholar] [CrossRef] [PubMed]
- Abba-Aji, M.; Stuckler, D.; Galea, S.; McKee, M. Ethnic/racial minorities’ and migrants’ access to COVID-19 vaccines: A systematic review of barriers and facilitators. J. Migr. Health 2022, 5, 100086. [Google Scholar] [CrossRef] [PubMed]
- Hussain, B.; Latif, A.; Timmons, S.; Nkhoma, K.; Nellums, L.B. Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies. Vaccine 2022, 40, 3413–3432. [Google Scholar] [CrossRef] [PubMed]
- Cesaroni, G.; Calandrini, E.; Balducci, M.; Cappai, G.; Di Martino, M.; Sorge, C.; Nicastri, E.; Agabiti, N.; Davoli, M. Educational Inequalities in COVID-19 Vaccination: A Cross-Sectional Study of the Adult Population in the Lazio Region, Italy. Vaccines 2022, 10, 364. [Google Scholar] [CrossRef] [PubMed]
- Benoni, R.; Sartorello, A.; Moretti, F.; Marchiori, F.; Accordini, L.; Postiglione, C.; Coffele, V.; Tardivo, S. Disparities in access to COVID-19 vaccine in Verona, Italy: A cohort study using local health immunization data. Front. Public Health 2023, 11, 1167414. [Google Scholar] [CrossRef]
- MacDonald, N.E.; SAGE Working Group on Vaccine Hesitancy. Vaccine hesitancy: Definition, scope and determinants. Vaccine 2015, 33, 4161–4164. [Google Scholar] [CrossRef]
- Baldissera, S.; Campostrini, S.; Binkin, N.; Minardi, V.; Minelli, G.; Ferrante, G.; Salmaso, S.; PASSI Coordinating Group. Features and initial assessment of the Italian Behavioral Risk Factor Surveillance System (PASSI), 2007–2008. Prev. Chronic Dis. 2011, 8, A24. [Google Scholar]
- Contoli, B.; Carrieri, P.; Masocco, M.; Penna, L.; Perra, A.; PDA Study Group. PASSI d’Argento (Silver Steps): The main features of the new nationwide surveillance system for the ageing Italian population, Italy 2013–2014. Ann. Ist. Super Sanita 2016, 52, 536–542. [Google Scholar]
- Campostrini, S. Behavioural Risk Factor Surveillance, Oxford Bibliographies, Public Health, 2020. Available online: https://www.oxfordbibliographies.com/view/document/obo-9780199756797/obo-9780199756797-0065.xml (accessed on 24 January 2024).
- Xu, F.; Town, M.; Balluz, L.S.; Bartoli, W.P.; Murphy, W.; Chowdhury, P.P.; Garvin, W.S.; Pierannunzi, C.; Zhong, Y.; Salandy, S.W.; et al. Surveillance for certain health behaviors among States and selected local areas—United States, 2010. MMWR Surveill. Summ. 2013, 62, 1–247. [Google Scholar] [PubMed]
- Decree of the President of the Council of Ministers of 3 March 2017. In Identification of Surveillance Systems and Registers of Mortality, Cancer and Other Diseases; (17A03142) (OJ General Series No. 109 of 12-05-2017); Decree of the President of the Council of Ministers: Rome, Italy, 2017.
- Gruppo Tecnico di Coordinamento del Progetto di sperimentazione del “Sistema di Sorveglianza PASSI. Sistema di Sorveglianza PASSI. Progressi delle Aziende Sanitarie per la Salute in Italia; Rapporti ISTISAN 07/30; Istituto Superiore di Sanità: Roma, Italy, 2007. [Google Scholar]
- Gruppo Tecnico di Coordinamento del Sistema di Sorveglianza PASSI d’Argento; Luzi, P. Sperimentazione PASSI d’Argento (Progressi delle Aziende Sanitarie per la Salute in Italia): Verso un Sistema Nazionale di Sorveglianza della Popolazione Ultra64enne; Rapporti ISTISAN 13/9; Istituto Superiore di Sanità: Roma, Italy, 2013. [Google Scholar]
- PASSI and PASSI d’Argento National Working Group. PASSI and PASSI d’Argento and COVID-19 Pandemic. First National Report on Results from the COVID Module; Istituto Superiore di Sanità: Roma, Italy, 2020. [Google Scholar]
- The American Association for Public Opinion Research (AAPOR). Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys, 10th ed.; AAPOR: St. Alexandria, VA, USA, 2023. [Google Scholar]
- Contoli, B.; Possenti, V.; Minardi, V.; Binkin, N.J.; Ramigni, M.; Carrozzi, G.; Masocco, M. What Is the Willingness to Receive Vaccination against COVID-19 among the Elderly in Italy? Data From the PASSI d’Argento Surveillance System. Front. Public Health 2021, 9, 736976. [Google Scholar] [CrossRef] [PubMed]
- Hamilton, L.C.; Seyfrit, C.L. Interpreting multinomial logistic regression. Stat. Technol. Bull. 1993, 13, 24–28. [Google Scholar]
- StataCorp. Stata Statistical Software: Release 16; StataCorp LP: College Station, TX, USA, 2019. [Google Scholar]
- Ministero della Salute (a). Ministero della salute. Raccomandazioni per l’organizzazione della campagna vaccinale contro SARS-CoV-2/COVID-19 e procedure di vaccinazione. 2020. Available online: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386716/pdf/vaccines-11-01223.pdf (accessed on 20 January 2024).
- Ministero della Salute (b). Ministero della salute. Piano strategico nazionale dei vaccini per la prevenzione delle infezioni da SARS-CoV-2. 2021. Available online: https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&codLeg=78657&parte=1%20&serie=null (accessed on 20 January 2024).
- IDOS. Dossier Statistico Immigrazione 2022. 2022. Available online: https://www.dossierimmigrazione.it/en/prodotto/dossier-statistico-immigrazione-2022/ (accessed on 20 January 2024).
- Fabiani, M.; Riccardo, F.; Di Napoli, A.; Gargiulo, L.; Declich, S.; Petrell, A. Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study. PLoS ONE 2016, 11, e0166517. [Google Scholar] [CrossRef] [PubMed]
- Alimoradi, Z.; Sallam, M.; Jafari, E.; Potenza, M.N.; Pakpour, A.H. Prevalence of COVID-19 vaccine acceptance among migrant and refugee groups: A systematic review and meta-analysis. Vaccine X 2023, 14, 100308. [Google Scholar] [CrossRef] [PubMed]
- Crawshaw, A.F.; Farah, Y.; Deal, A.; Rustage, K.; Hayward, S.E.; Carter, J.; Knights, F.; Goldsmith, L.P.; Campos-Matos, I.; Wurie, F.; et al. Defining the determinants of vaccine uptake and undervaccination in migrant populations in Europe to improve routine and COVID-19 vaccine uptake: A systematic review. Lancet Infect. Dis. 2022, 22, e254–e266. [Google Scholar] [CrossRef]
- Allen, K.; Lambert, S.B.; Yuen, A.; Pourmarzi, D. Factors associated with COVID19 booster vaccine willingness among migrants from the Eastern Mediterranean living in Australia: A crosssectional study. BMC Public Health 2022, 22, 2205. [Google Scholar] [CrossRef]
- Ferrara, M.; Bertozzi, G.; Volonnino, G.; Di Fazio, A.; Di Fazio, N.; Arcangeli, M.; La Russa, R.; Frati, P. Learning from the Past to Improve the Future—Vaccine Hesitancy Determinants in the Italian Population: A Systematic Review. Vaccines 2023, 11, 630. [Google Scholar] [CrossRef]
- Primieri, C.; Bietta, C.; Giacchetta, I.; Chiavarini, M.; de Waure, C. Determinants of COVID-19 vaccination acceptance or hesitancy in Italy: An overview of the current evidence. Ann. Ist. Super. Sanità 2023, 59, 10–25. [Google Scholar]
- Reno, C.; Maietti, E.; Fantini, M.P.; Savoia, E.; Manzoli, L.; Montalti, M.; Gori, D. Enhancing COVID-19 Vaccines Acceptance: Results from a Survey on Vaccine Hesitancy in Northern Italy. Vaccines 2021, 9, 378. [Google Scholar] [CrossRef]
- Moscardino, U.; Musso, P.; Inguglia, C.; Ceccon, C.; Miconi, D.; Rousseau, C. Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy. Vaccine 2022, 40, 2379–2387. [Google Scholar] [CrossRef] [PubMed]
- Zona, S.; Partesotti, S.; Bergomi, A.; Rosafio, C.; Antodaro, F.; Esposito, S. Anti-COVID Vaccination for Adolescents: A Survey on Determinants of Vaccine Parental Hesitancy. Vaccines 2021, 9, 1309. [Google Scholar] [CrossRef] [PubMed]
- Ministero della Salute (c). Ministero della salute. Aggiornamento sulle modalità d’uso del vaccino COVID-19 VACCINE ASTRAZENECA e delle raccomandazioni ad interim sui gruppi target della vaccinazione anti-SARS-CoV-2/COVID-19. 2021. Available online: https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2021&codLeg=78914&parte=1%20&serie=null (accessed on 20 January 2024).
- Gazzetta Ufficiale (a). Ministero della salute. Raccomandazioni ad interim sui gruppi target della vaccinazione anti SARS-CoV-2/COVID-19. 2021. Available online: https://www.gazzettaufficiale.it/eli/id/2021/03/24/21A01802/sg (accessed on 20 January 2024).
- Gazzetta Ufficiale (b). DECRETO-LEGGE 21 settembre 2021, n. 127. Misure urgenti per assicurare lo svolgimento in sicurezza del lavoro pubblico e privato mediante l’estensione dell’ambito ap-plicativo della certificazione verde COVID-19 e il rafforzamento del sistema di screening. Available online: https://www.gazzettaufficiale.it/eli/id/2021/09/21/21G00139/sg (accessed on 20 January 2024).
- Daniels, D.; Imdad, A.; Buscemi-Kimmins, T.; Vitale, D.; Rani, U.; Darabaner, E.; Shaw, A.; Shaw, J. Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis. Hum. Vaccines Immunother. 2022, 18, 6. [Google Scholar] [CrossRef] [PubMed]
- Gori, D.; Capodici, A.; La Fauci, G.; Montalti, M.; Salussolia, A.; Soldà, G.; Di Valerio, Z.; Scognamiglio, F.; Fantini, M.P.; Leask, J.; et al. COVID-19 Vaccine Refusal and Delay among Adults in Italy: Evidence from the OBVIOUS Project, a National Survey in Italy. Vaccines 2023, 11, 839. [Google Scholar] [CrossRef]
- Nelson, D.E.; Holtzman, D.; Bolen, J.; Stanwyck, C.A.; Mack, K.A. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soz. Praventivmed. 2001, 46 (Suppl. S1), S3–S42. [Google Scholar]
- ISTAT. DEMO. Demografia in Cifre. Available online: https://demo.istat.it/ (accessed on 30 November 2023).
- Ferroni, E.; Gennaro, N.; Maifredi, G.; Leoni, O.; Profili, F.; Stasi, C.; Cacciani, L.; Calandrini, E.; di Napoli, A.; Petrelli, A.; et al. Access to SARS-CoV-2 vaccination in immigrants in Italy, by geographical area of origin. Vaccine 2023, 42, 375–382. [Google Scholar] [CrossRef]
All | Italian Citizenship (n = 18,741) | Foreign Citizenship (n = 940) | |||||
---|---|---|---|---|---|---|---|
n | % | % | IC 95% | % | IC 95% | ||
Total | 19,681 | 100.0 | 94.8 | 94.4–95.2 | 5.2 | 4.8–5.6 | |
Sociodemographic factors | |||||||
Gender | Male | 9317 | 48.6 | 48.9 | 48.4–49.4 | 42.8 | 40.3–45.4 |
Female | 10,363 | 51.4 | 51.1 | 50.6–51.6 | 57.2 | 54.6–59.6 | |
Age | Mean (sd) | 48.8 (0.10) | - | 49.2 (0.10) | - | 43.0 (0.37) | - |
Educational level | Low | 5848 | 29.0 | 28.3 | 27.4–29.3 | 41.9 | 38.0–46.0 |
High | 13,785 | 71.0 | 71.6 | 70.7–72.5 | 58.1 | 54.0–62.0 | |
Economic difficulties | Yes | 7459 | 40.2 | 39.2 | 38.2–40.2 | 58.2 | 54.3–60.0 |
No | 12,096 | 59.8 | 60.8 | 59.8–61.8 | 41.8 | 38.0–45.7 | |
Geographic area of residence | North | 7232 | 32.8 | 31.2 | 30.8–31.6 | 61.8 | 59.4–64.1 |
Centre | 3991 | 18.6 | 18.2 | 17.9–18.4 | 26.1 | 24.5–27.8 | |
South | 8457 | 48.6 | 50.6 | 50.1–51.1 | 12.1 | 10.1–14.5 | |
Seasonal flu vaccination uptake | Yes | 5401 | 23.4 | 24.2 | 23.4–25.0 | 10.0 | 8.2–12.3 |
No | 14,251 | 76.6 | 75.8 | 75.0–76.5 | 90.0 | 87.7–91.9 | |
Period | 2020 | 10,023 | 53.5 | 53.6 | 52.8–54.3 | 51.7 | 47.8–55.5 |
2021 | 9657 | 46.5 | 46.4 | 45.7–47.1 | 48.3 | 44.5–52.2 | |
Noncommunicable chronic diseases | None | 14,397 | 76.1 | 75.8 | 74.8–76.7 | 82.9 | 79.9–85.6 |
At least one | 5273 | 23.9 | 24.2 | 23.3–25.2 | 17.1 | 14.4–20.1 | |
COVID-19 attitudes and experiences | |||||||
Probability of infection of SARS-Cov-2 | High | 7364 | 46.76 | 47.2 | 46.2–48.3 | 37.6 | 33.3–42.1 |
Low | 9686 | 53.24 | 46.3 | 45.3–47.4 | 48.7 | 44.2–53.2 | |
Reported intrusive thoughts | Yes | 5313 | 29.6 | 29.7 | 28.8–30.6 | 27.0 | 23.6–30.7 |
No | 13,755 | 70.4 | 70.3 | 69.4–71.2 | 73.0 | 69.3–76.4 | |
Reported being worried 1 | Yes | 13,936 | 71.9 | 72.5 | 71.5–73.5 | 60.3 | 56.2–64.2 |
No | 5491 | 28.1 | 27.5 | 26.5–28.5 | 39.7 | 35.8–43.8 | |
COVID-19 deaths in family or friends | Yes | 1262 | 6.3 | 6.3 | 5.8–6.8 | 6.2 | 4.5–8.5 |
No | 18,375 | 93.7 | 93.7 | 93.2–94.2 | 93.8 | 91.5–95.5 | |
Trust in local health unit management | Yes | 13,040 | 75.5 | 75.4 | 74.3–76.3 | 77.6 | 73.7–81.0 |
No | 4047 | 24.5 | 24.7 | 23.6–25.7 | 22.4 | 19.0–26.3 | |
COVID-19 cases in family, friends, or colleagues | Yes | 10,230 | 49.7 | 50.1 | 49.1–51.2 | 42.2 | 38.2–46.3 |
No | 9239 | 50.3 | 49.9 | 48.8–50.9 | 57.8 | 53.7–61.8 | |
Willingness to get vaccinated | Definitely yes | 12,063 | 60.1 | 60.7 | 60.0–61.7 | 49.4 | 45.5–53.4 |
Probably yes | 4417 | 23.3 | 23.3 | 22.5–24.2 | 23.5 | 20.3–27.1 | |
Probably no | 1795 | 9.4 | 9.1 | 8.5–9.7 | 15.1 | 12.4–18.2 | |
Definitely no | 1406 | 7.2 | 6.9 | 6.4–7.5 | 12.0 | 9.5–15.1 |
Italian Residents n = 18,741 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Multinomial Univariate | Multinomial Multivariate | ||||||||
Hesitancy | Hesitancy | ||||||||
Inclination versus Acceptance | Refusal versus Acceptance | Inclination versus Acceptance | Refusal versus Acceptance | ||||||
Characteristics | RRR * | 95% CI | RRR * | 95% CI | RRR * | 95% CI | RRR * | 95% CI | |
Sociodemographic factors | |||||||||
Gender | Female (ref. male) | 0.96 | (0.87–1.06) | 1.05 | (0.94–1.18) | 0.96 | (0.85–1.08) | 1.10 | (0.94–1.27) |
Age | 0.99 | (0.98–0.99) | 0.99 | (0.98–0.99) | 1.00 | (0.99–1.00) | 1.00 | (0.99–1.01) | |
Educational level | High (ref. low) | 0.81 | (0.73–0.91) | 0.53 | (0.47–0.60) | 0.76 | (0.66–0.88) | 0.52 | (0.43–0.61) |
Economic difficulties | Yes (ref. no) | 1.52 | (1.37–1.69) | 1.63 | (1.45–1.83) | 1.57 | (1.37–1.80) | 1.64 | (1.38–1.95) |
Geographic area of residence | Centre (ref. North) | 0.82 | (0.72–0.92) | 0.57 | (0.49–0.66) | 1.09 | (0.93–1.27) | 0.68 | (0.56–0.83) |
South (ref. North) | 0.89 | (0.80–0.98) | 0.60 | (0.53–0.68) | 0.77 | (0.67–0.89) | 0.50 | (0.42–0.60) | |
Seasonal flu vaccination uptake | Yes (ref. no) | 0.48 | (0.43–0.54) | 0.17 | (0.14–0.20) | 0.44 | (0.37–0.51) | 0.13 | (0.10–0.18) |
Period | 2021 (ref. 2020) | 0.28 | (0.25–0.31) | 0.46 | (0.41–0.51) | 0.24 | (0.21–0.28) | 0.33 | (0.29–0.39) |
Noncommunicable chronic diseases | At least one (ref. none) | 0.75 | (0.66–0.84) | 0.87 | (0.75–1.00) | 0.91 | (0.77–1.06) | 1.14 | (0.92–1.40) |
COVID-19 attitudes and experiences | |||||||||
Probability of infection of SARS-CoV-2 | High (ref. low) | 1.14 | (1.02–1.27) | 0.72 | (0.63–0.82) | 0.99 | (0.87–1.12) | 0.83 | (0.70–0.97) |
Reported intrusive thoughts | Yes (ref. no) | 0.76 | (0.67–0.85) | 0.74 | (0.64–0.85) | 0.80 | (0.69–0.92) | 0.88 | (0.72–1.07) |
Reported being worried 1 | Yes (ref. no) | 1.42 | (1.25–1.61) | 0.65 | (0.57–0.74) | 1.24 | (1.06–1.44) | 0.62 | (0.52–0.73) |
Trust in management capacity of local health unit | No (ref. yes) | 1.13 | (0.99–1.30) | 2.12 | (1.84–2.44) | 1.08 | (0.93–1.26) | 2.15 | (1.82–2.54) |
COVID-19 deaths in family or friends | Yes (ref. no) | 0.64 | (0.52–0.79) | 0.61 | (0.47–0.78) | 0.78 | (0.60–1.01) | 0.83 | (0.60–1.15) |
COVID-19 cases among family, friends, or colleagues | Yes (ref. no) | 0.78 | (0.71–0.87) | 0.65 | (0.58–0.73) | 0.92 | (0.81–1.04) | 0.69 | (0.59–0.80) |
Foreign Residents n = 940 | |||||||||
---|---|---|---|---|---|---|---|---|---|
Multinomial Univariate | Multinomial Multivariate | ||||||||
Hesitancy | Hesitancy | ||||||||
Inclination versus Acceptance | Refusal versus Acceptance | Inclination versus Acceptance | Refusal versus Acceptance | ||||||
Characteristics | RRR * | 95% CI | RRR * | 95% CI | RRR * | 95% CI | RRR * | 95% CI | |
Sociodemographic factors | |||||||||
Gender | Female (ref. male) | 1.16 | (0.77–1.74) | 1.48 | (0.99–2.21) | 1.07 | (0.62–1.83) | 1.68 | (1.01–2.79) |
Age | 1.00 | (0.98–1.01) | 1.00 | (0.99–1.02) | 1.00 | (0.98–1.02) | 1.01 | (0.99–1.03) | |
Educational level | High (ref. low) | 0.83 | (0.55–1.25) | 1.57 | (1.04–2.36) | 0.75 | (0.44–1.28) | 1.30 | (0.76–2.21) |
Economic difficulties | Yes (ref. no) | 1.54 | (0.99–2.37) | 1.16 | (0.78–1.73) | 1.69 | (0.97–2.95) | 1.63 | (0.96–2.75) |
Geographic area of residence | Centre (ref. North) | 0.87 | (0.58–1.30) | 0.50 | (0.32–0.76) | 1.07 | (0.63–1.81) | 0.64 | (0.3511–1.18) |
South (ref. North) | 0.60 | (0.33–1.09) | 0.67 | (0.36–1.25) | 0.75 | (0.40–1.42) | 0.53 | (0.25–1.13) | |
Seasonal flu vaccination uptake | Yes (ref. no) | 0.66 | (0.38–1.15) | 0.25 | (0.12–0.52) | 0.44 | (0.21–0.93) | 0.10 | (0.03–0.34) |
Period | 2021 (ref. 2020) | 0.38 | (0.25–0.57) | 0.35 | (0.24–0.52) | 0.42 | (0.25–0.70) | 0.29 | (0.18–0.48) |
Noncommunicable chronic diseases | At least one (ref. none) | 0.89 | (0.52–1.50) | 0.90 | (0.56–1.46) | 0.88 | (0.44–1.75) | 1.21 | (0.63–2.29) |
COVID-19 attitudes and experiences | |||||||||
Probability of infection of SARS-CoV-2 | High (ref. low) | 1.23 | (0.79–1.90) | 0.54 | (0.33–0.88) | 1.07 | (0.63–1.82) | 0.56 | (0.32–0.97) |
Reported intrusive thoughts | Yes (ref. no) | 0.84 | (0.53–1.30) | 0.52 | (0.33–0.83) | 0.67 | (0.37–1.21) | 0.63 | (0.33–1.19) |
Reported being worried 1 | Yes (ref. no) | 2.07 | (1.34–3.17) | 0.65 | (0.43–0.97) | 1.87 | (1.07–3.28) | 0.51 | (0.30–0.88) |
Trust in management capacity of local health unit | No (ref. yes) | 1.78 | (1.03–3.06) | 1.98 | (1.16–3.38) | 1.59 | (0.85–2.95) | 1.79 | (0.96–3.35) |
COVID-19 deaths in family or friends | Yes (ref. no) | 0.94 | (0.42–2.10) | 0.33 | (0.12–0.92) | 1.04 | (0.37–2.93) | 0.46 | (0.12–1.80) |
COVID-19 cases among family, friends, or colleagues | Yes (ref. no) | 1.36 | (0.90–2.04) | 0.931 | (0.62–1.39) | 1.35 | (0.77–2.33) | 1.33 | (0.78–2.29) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Contoli, B.; Tosti, M.E.; Asta, F.; Minardi, V.; Marchetti, G.; Casigliani, V.; Scarso, S.; Declich, S.; Masocco, M. Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems. Vaccines 2024, 12, 124. https://doi.org/10.3390/vaccines12020124
Contoli B, Tosti ME, Asta F, Minardi V, Marchetti G, Casigliani V, Scarso S, Declich S, Masocco M. Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems. Vaccines. 2024; 12(2):124. https://doi.org/10.3390/vaccines12020124
Chicago/Turabian StyleContoli, Benedetta, Maria Elena Tosti, Federica Asta, Valentina Minardi, Giulia Marchetti, Virginia Casigliani, Salvatore Scarso, Silvia Declich, and Maria Masocco. 2024. "Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems" Vaccines 12, no. 2: 124. https://doi.org/10.3390/vaccines12020124
APA StyleContoli, B., Tosti, M. E., Asta, F., Minardi, V., Marchetti, G., Casigliani, V., Scarso, S., Declich, S., & Masocco, M. (2024). Exploring COVID-19 Vaccination Willingness in Italy: A Focus on Resident Foreigners and Italians Using Data from PASSI and PASSI d’Argento Surveillance Systems. Vaccines, 12(2), 124. https://doi.org/10.3390/vaccines12020124